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Biocatalytic Dynamic Kinetic Resolution for the Synthesis of 
Atropisomeric Biaryl N-Oxide Lewis Base Catalysts 
Samantha Staniland[a], Ralph W. Adams[a], Joseph J. W. McDouall[a], Irene Maffucci[b], Alessandro 
Contini[b], Damian Grainger[c], Nicholas J. Turner*[d], Jonathan Clayden*[e] 
Abstract: Atropisomeric biaryl pyridine and isoquinoline N-oxides 
were synthesized enantioselectively by dynamic kinetic resolution 
(DKR) of rapidly racemising precursors exhibiting free bond rotation. 
The DKR was achieved by ketoreductase (KRED) catalysed 
reduction of an aldehyde to form a configurationally stable 
atropisomeric alcohol, with the substantial increase in rotational 
barrier arising from the loss of a bonding interaction between the N-
oxide and the aldehyde. Use of different KREDs allowed either the M 
or P enantiomer to be synthesized in excellent enantiopurity. The 
enantioenriched biaryl N-oxide compounds catalyse the asymmetric 
allylation of benzaldehyde derivatives with allyltrichlorosilane. 
Biaryl atropisomers provide an important class of structure 
with extensive utility in asymmetric synthesis, particularly as 
ligands inducing asymmetric catalysis by metals.[1] Atropisomers 
are also used as catalysts in their own right. BINOL derived 
phosphoric acids have been utilised as Brønsted acid catalysts[2] 
and atropisomeric quinoline N-oxides such as QUINOX[3] are 
excellent Lewis base catalysts for various asymmetric 
transformations incuding asymmetric allylation of substituted 
benzaldehydes,[4,5] asymmetric desymmetrisations of meso 
epoxides[6] and asymmetric aldol reactions.[7] 
The need for efficient methods for the enantioselective 
synthesis of atropisomers[8] has encouraged the development of 
atroposelective transition metal couplings,[9] kinetic resolution by 
metal catalysis[10] and organocatalytic methods,[11] and 
desymmetrisation.[12] The potential for subtle control of 
racemisation rates in atropisomeric and near-atropisomeric 
structures allows the efficient use of dynamic kinetic[13] or 
thermodynamic[14] resolution. Although biocatalytic methods are 
particularly effective for achieving kinetic resolution and dynamic 
kinetic resolution,[15] biocatalytic dynamic kinetic resolution 
(DKR) has never been used to synthesise atropisomers 
enantioselectively.[16] In this paper we describe the first use of 
biocatalytic DKR for the asymmetric synthesis of some novel 
catalytically active biaryl atropisomers. 
In an effective DKR,[17] an enantioselective transformation 
must take place more slowly than the racemisation of the 
starting materials but faster than the racemisation of the 
products. This requirement makes DKR a particularly appealing 
strategy for the synthesis of atropisomers, since their 
racemisation entails a simple bond rotation that may be fine-
tuned using steric or electronic substituent effects. For a 
practical biocatalytic DKR this substrate racemisation must take 
place on a timescale of minutes or less within a temperature 
range at which the enzyme can operate (typically 20-50 °C), 
while the product must be atropisomerically stable over at least 
hours at this temperature. We reasoned that such a substantial 
decrease in racemisation rate could be achieved by a functional 
group interconversion in which a small, planar substituent such 
as an aldehyde is converted to a larger, tetrahedral 
substituent.[18] Atropisomeric alcohols of general structure 3 are 
useful chiral ligands for asymmetric synthesis,[19] so we set out 
to explore the possibility of making them enantioselectively by 
dynamic kinetic resolution of the biaryl aldehydes 1. 
 
Scheme 1. Biaryl aldehyde substrates for KR and DKR. [a] PdRuPhos (3 
mol%), CsF (3.0 equiv), THF, reflux, 86%; [b] PPTS (0.6 equiv), EtOH, 73%; 
[c] MnO2 (10.0 equiv), CH2Cl2, r.t. 86%.; [d] m-CPBA (1.5 equiv), CH2Cl2, r.t., 
74% 
Initial studies focused on aldehyde 1a, but this turned out 
to be unstable towards an oxidative cyclisation (see SI), so its 
isoquinoline nitrogen atom was protected in the form of the N-
oxide derivative 2a. Suzuki coupling of boronate ester 6 with 1-
bromoisoquinoline 5 in 86% yield was followed by THP ether 
deprotection to give 3a in 73% yield (Scheme 1). Oxidation to 
the N-oxide 4a in 74% yield and a second oxidation with MnO2 in 
86% yield gave aldehyde 2a. The stability of 2a towards 
racemisation was estimated by micropreparative separation of 
its enantiomers by HPLC on a chiral stationary phase, 
monitoring their subsequent decay in ee of 2a over time. No loss 
in ee was observed after 5 h in xylenes at 100 °C, and at 138 °C 
decomposition occurred faster than racemisation. A substrate 
racemising this slowly is not a suitable candidate for a DKR 
process, so 2a was used instead as a model to determine the 
ability of commercially available ketoreductase enzymes 
(KREDs) to distinguish the enantiomers of this family of biaryl 
aldehydes in a non-dynamic kinetic resolution. Aldehyde 2a was 
incubated at 30 °C for 16 h with a series of KREDs in the 
presence of a glucose/glucose dehydrogenase (GDH)/NADP 
cofactor recycling system,[20] and the results are shown in Table 
1. 
KREDs (Codexis) 113, 110, 112 and 114 (Entries 5, 7, 8 
and 9) gave excellent results, selectively reducing one 
enantiomer of aldehyde 2a to give the alcohol 4a in 98 to >99% 
N
O
N
OH
1 (Z = : )
2 (Z = O)
3 (Z = : )
4 (Z = O)
enzymatic
reduction
X
Y
X
Y
Z Z
N
Br
OTHP
B
OO
6
5
[a], [b]
N
OH
3a
N
OH
O
N
O
O [c][d]
4a2a
´
[O]
1a
atropselective
dynamic
kinetic
resolution
[a] Dr. S. Staniland, Dr. R. Adams, Dr. J. J. W. McDouall  
  School of Chemistry, University of Manchester, Oxford Road 
Manchester M13 9PL, UK 
[b] Dr A. Contini, Dr I. Maffucci, Università di Milano, Dipartimento 
Scienze Farmaceutiche – Sezione di Chimica Generale e Organica 
“Alessandro Marchesini”, Università degli Studi di Milano, Via 
Venezian, 21 20133 Milano, Italy 
[c] Dr. D. M. Grainger  
Johnson Matthey Catalysis and Chiral Technologies 
 28 Science Park, Milton Road,  
Cambridge, CB4 0FP, UK 
[d] Prof. N. J. Turner, School of Chemistry, University of Manchester, 
Manchester Institute of Biotechnology, 131 Princess Street, 
Manchester M1 7DN, UK 
Fax: (+44)161-275-1311 E-mail: nicholas.turner@manchester.ac.uk 
 [e] Prof. J. Clayden, School of Chemistry, University of Bristol, 
Cantock's Close, Bristol BS8 1TS, UK; E-mail: 
j.clayden@bristol.ac.uk 
 Supporting information for this article is given via a link at the end of 
the document. 
COMMUNICATION          
 
 
 
 
ee respectively and with yields of 46-51%. KRED 130 by 
contrast (Entry 13) showed high reactivity but low 
enantioselectivity, producing alcohol 4a in 93% yield with 20% 
ee. These high enantioselectivities indicated that the enzyme 
active site was able to distinguish highly effectively the two 
enantiomeric atropisomers of a 2-arylisoquinoline-N-oxide, so 
we set about modifying the substrates in order to increase the 
rate of racemisation of these substrates. 
Table 1. Kinetic resolution of racemic aldehyde 2a using a panel of KREDs.  
 
Entry KRED 4a [%]a 
4a eeb 
[%] 
2a [%] 
2a eeb 
[%] 
1 102 4 22 96 0 
2 105 0 - 100 - 
3 107 0 - 100 - 
4 108 3 60 97 3 
5 110 54 63 46 98 
6 111 0 - 100 - 
7 112 51 67 49 99 
8 113 54 65 46 >99 
9 114 49 77 51 98 
10 119 40 87 60 72 
11 123 31 72 69 45 
12 124 62 44 38 99 
13 130 93 1 7 20 
14 nonec 13 100 87 23 
a % conversion determined by HPLC. b Absolute configuration not known. 
cReaction mixture still contains GDH. 
Two less hindered biaryl N-oxides, the 1-
phenylisoquinoline-N-oxide 2b and the 2-(1-naphthyl)pyridine-N-
oxide 2c, were made by Suzuki coupling (Scheme 2). 
Preliminary analysis by HPLC suggested that both aldehydes 
were unstable towards racemisation at room temperature: 
attempted resolution on a chiral stationary phase at 30 °C 
resulted in a single broad peak in both cases. By contrast, 
racemic samples of the corresponding alcohols 4b and 4c each 
clearly showed two distinct enantiomeric peaks on the same 
chiral stationary phase (see SI), indicating that, as hoped, both 
4b and 4c had a substantially higher barrier to rotation than the 
corresponding aldehydes. 
  
Scheme 2. Synthesis of less hindered biaryl N-oxide aldehydes 2b, 2c and 
alcohols 4b, 4c, along with models 7 and 8..  Δ𝐺𝑇 
‡
 indicates the barrier to 
enantiomerisation (Ar–Ar bond rotation) at T K. [a] Pd(PPh3)4 (10 mol%), 
K2CO3 (3.0 equiv), dioxane, reflux; [b] NaBH4, MeOH. 
The rotational barriers of the configurationally unstable 
aldehydes 2b and 2c were determined more accurately by VT 
1H NMR analysis in toluene-d8 in the presence of the chiral 
solvating reagent, (R)-1-anthracen-9-yl-2,2,2-trifluoroethanol (1 
equiv.). VTNMR and line-shape analysis of the resulting pair of 
diastereoisomeric aldehyde CHO resonances (see SI) gave 
values for the barrier to enantiomerisation of Δ𝐺298 K 
‡
 = 68.1 kJ 
mol-1 for 2b and Δ𝐺298 K 
‡
 = 65.7 kJ mol-1 for 2c, both 
corresponding to half-lives of seconds or less at ambient 
temperatures. The barriers to Ar–Ar bond rotation in the alcohols 
4b and 4c were calculated from the rate of first-order decay in 
ee over time at 90 °C in xylenes (see SI) of samples resolved by 
semi-preparative HPLC on a chiral stationary phase. For 4b 
Δ𝐺363 K
‡
 = 120.7 kJ mol-1, corresponding to a half-life to 
racemisation at 90 °C of 2.9 h; for 4c, Δ𝐺363 K
‡
 = 115.1 kJ mol-1, 
corresponding to a half-life to racemisation at 90 °C of 45 min.  
The substantially greater configurational stability of the alcohols 
over the aldehydes allows a usefully large window for a potential 
dynamic kinetic resolution on a time scale intermediate between 
the two time scales of racemisation. 
The panel of KREDs were screened against substrates 2b 
and 2c on an analytical scale (1 mL, 2.5 mg substrate). 
Remarkably, KREDs 108, 112, 119 and 130 (Table 2, Entries 4, 
7, 9 and 12) performed almost perfect DKR of 2b. The 
atropisomeric alcohol (S)-4b was obtained in 100% yield (based 
on full conversion by HPLC), with enantioselectivities of 96, 98 
and 94% ee. Furthermore, KRED 130, (Entry 12) showed 
opposite selectivity to KREDs 108, 112 and 119 (Entries 4, 7 
and 9), giving (R)-4b enantiomer in excellent ee (>99%). The 
ability to access both enantiomers of the product is an attractive 
feature of the method, and scaling the reaction to 500 mg of 
substrate (entry 12) returned a preparatively useful quantity of 
(R)-4b. This result represents the first example of a biocatalytic 
DKR for the asymmetric synthesis of an enantiopure axially 
chiral biaryl. A control experiment in the absence of KRED 
(Entry 13) confirmed that background reduction by the glucose 
dehydrogenase (GDH) used for cofactor recycling was not 
responsible for the DKR. 
 
Table 2. Dynamic Kinetic resolution of aldehyde 2b using a panel of KREDs.  
 
 
Entry KRED 4b [%]a 4b ee [%] Configurationb 
1 102 21 7 R 
2 105 4 >99 R 
3 107 5 >99 R 
4 108 100 96 S 
5 110 59 99 S 
6 111 5 >99 R 
7 112 100 98 S 
8 113 93 95 S 
9 119 100 94 S 
10 123 22 16 S 
11 124 73 68 S 
12 130 100, 83c >99 R 
13 none 0 - - 
KRED, 30 °C, 16 h
NADPH NADP
glucose
GDH
gluconic acid
(±)-2a 4a
[in 46% yield,
>99% ee
after 24 h with
KRED 113]
+ 2a
N
O
O
N
O
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–1
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Y
X
Y
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O
X
Y
2c (with ring Y): 
DG‡298 = 65.7 kJ mol
–1
4b (with ring X): 
DG‡363 = 120.7 kJ mol
–1
4c (with ring Y): 
DG‡363 = 115.1 kJ mol
–1
O
Br
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KRED, 30 °C, 16 h
NADPH NADP
glucose
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gluconic acid
(±)-2b
OH
N
O
(R)-4b
83%, >99% ee
on 500 mg scale
(with KRED 130)
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a % conversion determined by HPLC.  b Configuration assigned by comparing 
experimental and calculated circular dichroism spectra (see Fig. 1). c Isolated 
yield on 500 mg scale. 
Table 3. Dynamic Kinetic resolution of aldehyde 2c using a panel of KREDs.  
 
Entry KRED 4c [%]a 
4c ee 
[%] 
Configuration.b 
1 102 21 55 S 
2 105 5 76 S 
3 107 11 33 R 
4 108 21 82 S 
5 110 100 4 R 
6 111 25 74 S 
7 112 100 54 S 
8 113 100 8 R 
9 119 77 23 S 
10 123 7 11 S 
11 124 100 73 R 
12 130 100, 73c 96 S 
13 none 3 36 S 
14 noned 0 - - 
15 130d 42 96 S 
a % conversion determined by HPLC.  b Configuration assigned by comparing 
experimental and calculated circular dichroism spectra (see Fig. 1). c Isolated 
yield on 500 mg scale.  d Formate dehydrogenase (FDH) used instead of GDH, 
with formic acid as reductant. 
Substrate 2c was screened with the same series of 
KREDs and again excellent conversions (100%) were obtained, 
this time with KREDs 110, 112, 113, 124 and 130 (Table 3, 
entries 5, 7, 8, 11 and 12). In general the enantioselectivities 
were lower than with 2b, but nonetheless KRED 130 (entry 12) 
produced (S)-4c in 96% ee and 100% yield. In this case, a 
background reaction occurred in the absence of the KRED 
(entry 13) suggesting that GDH was able to catalyse the 
reduction in 3% yield and 36% ee. GDH is known to have some 
substrate promiscuity,[21] so the reaction was repeated using 
formate dehydrogenase (FDH) and formic acid as the co-factor 
recycling system. No background reaction was observed (entry 
14). The enantioselectivity with KRED 130 with FDH recycling 
remained high (96% ee), so any background reaction from using 
GDH can be disregarded. Again, the reaction performed well on 
scale-up, giving 73% of (S)-4c (96% ee) on a 500 mg scale 
(entry 12). 
The absolute configuration of alcohols 4b and 4c was 
assigned by comparison of their electronic circular dichroism 
spectra (Figure 1, solid lines) with CD spectra calculated by 
time-dependent DFT (Figure 1, dashed lines: see SI). 
Intriguingly, KRED 130 reduced 2b to give (R)-4b but reduced 
2c to give (S)-4c. 
 
Figure 1. Experimental (solid line) and calculated (dashed line) electronic 
circular dichroism spectra (a) of (R)-4b and (b) of (S)-4c. 
 
Figure 2. Bonding interaction at the transition state for enantiomerisation of 2. 
The successful DKR is made possible by the substantial 
difference in barriers to Ar–Ar bond rotation between the 
aldehydes 2 and the alcohols 4. To explore the possibility that a 
bonding interaction between the N-oxide substituent and the 
formyl group in 2 accelerates its racemisation (Figure 2),[22] 
isosteric fluorinated compounds 7 and 8 were made (Scheme 2) 
in which this possibility is greatly reduced. While the barrier to 
bond rotation in alcohol 8 is similar to that in alcohols 4, the 
barrier to bond rotation in 7 is significantly higher than that in 2, 
suggesting that the transition state for enantiomerisation of 2 
benefits from the stabilising bonding interaction illustrated in 
Figure 2. Molecular modelling (described in full in the SI) 
supports this interpretation, indicating pyramidalisation of the 
aldehyde at the transition state (Fig 2) as a consequence of this 
interaction.[23] 
In common with biaryl N-oxides such as QUINOX,[3] the 
biaryl N-oxides formed by biocatalytic DKR turned out to be 
effective Lewis base organocatalysts for the asymmetric 
allylation of aldehydes. Using the method of Hayashi et al.[4], 
allyltrichlorosilane (1.1 equiv.) and the aldehyde (1.0 equiv.) 
were stirred in either acetonitrile or dichloromethane at 45 °C in 
the presence of 0.1-1 mol% N-oxide catalyst for 6 h. Three 
substituted benzaldehydes were employed (9a-c), and 
enantiomeric excesses of up to 80% were obtained in the 
presence of (S)-4c (0.1 mol%). 
 
Table 4: Allylation of benzaldehydes using 4 as organocatalysts. 
O
N
O
KRED, 30 °C, 16 h
NADPH NADP
glucose
GDH
gluconic acid
(±)-2c
OH
N
O
(S)-4c
73%, 96% ee
on 500 mg scale
(with KRED 130)
[+ insert Irene picture of TS]
N
O
O
H
(–)
(–)
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Entry Catalyst 
R = 
10 [%] 
10 ee 
[%] 
Configuration 
1 (R)-4b CF3 15 32 S 
2 (R)-4b H 22 34 S 
3 (R)-4b OMe 17 17 S 
4 (S)-4ca CF3 28 50 R 
5 (S)-4ca H 66 48 R 
6 (S)-4ca OMe 50 76 R 
7 (S)-4ca, b OMe 27 80 R 
a Catalyst has 96% ee. b 0.1 mol% catalyst loading. 
In summary, the first asymmetric synthesis of atropisomers 
by dynamic kinetic resolution using biocatalysis gives access to 
new biaryl N-oxide scaffolds in excellent ee and yields in three 
steps from commercially available starting materials. Structural 
features in the aldehydes facilitate rapid racemisation at ambient 
temperatures required for the asymmetric biocatalytic 
transformation. The N-oxides act as Lewis base organocatalysts 
for the asymmetric allylation of aldehydes. Biocatalytic DKR 
offers rich possibilities for the synthesis of atropisomers without 
recourse to traditional resolution. 
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racemising biaryl aldehydes 
yields, by highly selective 
dynamic kinetic resolution 
(DKR), single enantiomers of 
atropisomeric biaryls in high 
yield and high ee.  This first 
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pyridine-N-oxide and primary 
alcohol groups and function as 
catalysts of asymmetric 
aldehyde allylation. 
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